Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-cola Euro. Regulatory News (CCEP)

Share Price Information for Coca-cola Euro. (CCEP)

Share Price is delayed by 15 minutes
Get Live Data
7,405.00    20.00 (0.27%)
Bid:
7,405.00
Ask:
7,415.00
Spread: 10.00 (0.135%)
Market Cap: £32.79b
CCEP Live PriceLast checked at - London Stock Exchange

Intraday Coca-cola Euro. Share Chart

Directorate change

4 Mar 2026 16:00

RNS Number : 3658V
Coca-Cola Europacific Partners plc
04 March 2026
Β 

CHANGES TO DIRECTORS OF COCA-COLA EUROPACIFIC PARTNERS PLC

Coca-Cola Europacific Partners plc (CCEP) today announces that Guillaume Bacuvier, Independent Non-executive Director (INED) will retire from the Board with effect from the conclusion of the forthcoming Annual General Meeting (AGM) to be held on 28 May 2026.

Guillaume has served as an INED of CCEP since January 2024 and as a member of the Remuneration Committee. His perspectives on consumer behaviours and strategy, as well as marketing effectiveness insights from across Europe and APAC have been invaluable to the Board. In view of his recent move to a new role requiring more of his time he will be retiring from the Board as of the AGM.

As part of the Board's succession planning, and following a comprehensive search and selection process, the appointment of Uvashni Raman as an INED was approved on 4 March 2026 and will be effective from the conclusion of the AGM on 28 May 2026.

Sol Daurella, Chairman said, "On behalf of the Board, I would like to sincerely thank Guillame for his great contributions to our business. He has brought a wealth of experience in data and technology and we all wish him the very best with his future endeavours. I would also like to welcome Uvashni and very much look forward to working with her."

About Uvashni Raman

Uvashni brings extensive financial and operational experience to the Board across both European and global markets. She has a strong track record as a CFO and divisional Financial Director in listed and private companies spanning the technology, consumer, media and mining sectors. Her experience includes leading large, complex organisations through sustained growth, with expertise across finance, procurement, operations, strategy, M&A, sustainability, capital markets, corporate affairs and business transformation.

Uvashni is currently Chief Financial Officer of Booking.com, having been appointed in October 2023. Her prior roles include Group CFO of Adevinta (2019-2023), CFO for Naspers Video Entertainment Division (2016-2019), South 32 Australian Region (2015-2016) and she held multiple CFO, commercial, operational and strategic finance roles within BHP.

There are no further matters that need to be disclosed pursuant toΒ UKΒ Listing Rule 6.4.8 R.

Β 

CONTACTS

Β 

Β 

Β 

Company Secretariat

Clare Wardle

clare.wardle@ccep.com

Β 

Investor Relations

Sarah Willett

sarah.willett@ccep.com

Media Relations

Shanna Wendt

mediaenquiries@ccep.com

Β 

ABOUT CCEP

Coca-Cola Europacific PartnersΒ is one of the world's leading consumer goods companies. We make, move and sell some of the world's most loved brands - serving nearly 600 million consumers and helping over 4 million customers across 31 countries grow.

We combine the strength and scale of a large, multi-national business with an expert, local knowledge of the customers we serve and communities we support.

The Company is currently listed on Euronext Amsterdam, NASDAQ, London Stock Exchange and on the Spanish Stock Exchanges, and a constituent of both the NASDAQ 100 and FTSE 100 indices, trading under the symbol CCEP (ISIN No. GB00BDCPN049).

For more information about CCEP, please visitΒ www.cocacolaep.comΒ and follow CCEP onΒ LinkedIn

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOAFLFFEVIISIIR
Date   Source Headline
12th Jun 20264:30 pmRNSDirector/PDMR Shareholding
5th Jun 20263:30 pmRNSDirector/PDMR Shareholding
3rd Jun 202612:30 pmRNSDirector/PDMR Shareholding
1st Jun 20261:30 pmRNSTotal Voting Rights
29th May 20261:00 pmRNSResult of AGM
21st May 20263:30 pmRNSDirector/PDMR Shareholding
18th May 202611:00 amRNSLetter to Shareholders
1st May 20264:15 pmRNSDirector/PDMR Shareholding
1st May 20261:30 pmRNSTotal Voting Rights
28th Apr 20267:00 amRNSQ1 Trading Update & Interim Dividend Declaration
27th Apr 20263:00 pmRNSTransactions in Own Shares
22nd Apr 20262:15 pmRNSDirector/PDMR Shareholding
20th Apr 20261:30 pmRNSTransactions in Own Shares
16th Apr 20269:15 amRNSNotice of AGM
15th Apr 202610:30 amRNSDirector/PDMR Shareholding
13th Apr 202612:30 pmRNSTransaction in Own Shares
10th Apr 202611:00 amRNSSID Appointment and Board Committee Changes
7th Apr 20262:00 pmRNSTransaction in Own Shares
1st Apr 20262:30 pmRNSTotal Voting Rights
1st Apr 202611:00 amRNSChange of Company Secretary
30th Mar 20263:30 pmRNSTransactions in Own Shares
27th Mar 20269:00 amRNSDirector/PDMR Shareholding
24th Mar 202612:00 pmRNSDirector/PDMR Shareholding
23rd Mar 20267:00 amRNSTransactions in Own Shares
20th Mar 20264:45 pmRNSDirector/PDMR Shareholding
20th Mar 20267:00 amRNSTransactions in Own Shares
19th Mar 20267:00 amRNSTransactions in Own Shares
18th Mar 20267:00 amRNSTransactions in Own Shares
17th Mar 20267:00 amRNSTransactions in Own Shares
17th Mar 20267:00 amRNSTransactions in Own Shares
16th Mar 20265:00 pmRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSTransactions in Own Shares
16th Mar 20267:00 amRNSTransactions in Own Shares
13th Mar 202612:11 pmRNSAnnual Financial Report
13th Mar 202612:11 pmRNSAnnual Financial Report
13th Mar 20267:00 amRNSTransactions in Own Shares
13th Mar 20267:00 amRNSTransactions in Own Shares
12th Mar 20267:00 amRNSTransactions in Own Shares
12th Mar 20267:00 amRNSTransactions in Own Shares
11th Mar 20267:00 amRNSTransactions in Own Shares
10th Mar 20267:00 amRNSTransactions in Own Shares
9th Mar 20267:00 amRNSTransactions in Own Shares
6th Mar 20267:00 amRNSTransactions in Own Shares
5th Mar 20267:00 amRNSTransactions in Own Shares
4th Mar 20264:00 pmRNSDirectorate change
4th Mar 20267:00 amRNSTransactions in Own Shares
3rd Mar 20265:13 pmRNSDirector/PDMR Shareholding
3rd Mar 20265:00 pmRNSHolding(s) in Company
3rd Mar 20267:00 amRNSTransactions in Own Shares
2nd Mar 20261:15 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.